Search Results for "Nautilus Biotech"
Original Source: Nautilus Biotech
Our mission is to develop and market innovative biotechnology products for a better quality of life.Our success is based on a continuous focus on increasing shareholder value, and upon the contributions of employees who share a common vision of solving health challenges by creating innovative technologies and products.Transparency, accountability and financial discipline have created trust and sustained support from our investors and partners.We develop proprietary improved protein-based products to maximis...
Matching Channels
Able to take advantage of a €2 European funding stimulus in 2009, the Czech Republic is one of Europe's top 5 centers for biotechnology companies. In just over decade, the Czech Republic ha...
India, in the Asian subcontinent is the world’s fourth largest producer of pharmaceuticals, and is thought as one of the most promising biotech markets in the world. Several important steps...
In addition to the Silicon Valley, California on the west coast of the USA is home to a biotechnology hub. 26% of all American biotechnology firms are located in this state, but they count for over...
Carolina, on the southeastern US coast is a hotbed for biotechnology companies. The regional industry support organization, The North Carolina Biotechnology Center, is the oldest of its type in th...
Matching News
Nautilus, Inc. to Present at the 14th Annual B. Riley & Co. Investor Conference
May 14, 2013 -- Nautilus, Inc. (NYSE: NLS) today announced that Bruce M. Cazenave, Chief Executive Officer, Linda M. Pearce, Chief Financial Officer, and William B. McMahon, Chief...
Nautilus, Inc. to Present at 15th Annual ICR XChange
January 7, 2013 -- Nautilus, Inc. (NYSE: NLS) today announced that Bruce M. Cazenave, Chief Executive Officer, Linda M. Pearce, Chief Financial Officer, and William B. McMahon, Ch...
Nautilus, Inc. to Announce First Quarter 2013 Results on Monday, May 6, 2013
April 25, 2013 -- Nautilus, Inc. (NYSE: NLS) today announced that the Company will report its financial results for the first quarter ended March 31, 2013 after the market closes...
'Practicing Sustainability' chosen for a silver Nautilus Book Award
(Springer Science+Business Media ) Practicing Sustainability, published by Springer, has been selected as a silver-award winner of the 2013 Nautilus Book Awards, in the "Green Living / Sustainability"...
Nautilus, Inc. to Announce Fourth Quarter 2012 Results on Monday, March 4
February 21, 2013 -- Nautilus, Inc. (NYSE: NLS) today announced that the Company will report its financial results for the fourth quarter ended December 31, 2012 after the market...
Nautilus, Inc. to Announce Second Quarter 2012 Results on Monday, August 6
July 27, 2012 -- Nautilus, Inc. (NYSE: NLS) today announced that the Company will report its financial results for the second quarter ended June 30, 2012 after the market closes o...
Nautilus, Inc. to Announce Third Quarter 2012 Results on Monday, November 5
October 29, 2012 - Nautilus, Inc. (NYSE: NLS) today announced that the Company will report its financial results for the third quarter ended September 30, 2012 after the market cl...
Vertical Pharmaceuticals, Nautilus Neurosciences sign co-promotion agreement for Lorzone
Vertical Pharmaceuticals, Inc. today announced that Vertical and Nautilus Neurosciences have entered into a co-promotion agreement for Lorzone (chlorzoxazone tablets, USP), a safe, effective, and fast...
Matching PubMed Articles
Loss of the six3/6 controlling pathways might have resulted in pinhole-eye evolution in Nautilus.
Coleoid cephalopods have an elaborate camera eye whereas nautiloids have primitive pinhole eye without lens and cornea. The Nautilus pinhole eye provides a unique example to explore the module of lens...
Reply to "Comment on 'Single-Ion Activity: Experiment versus Theory'".
Biotech 101: An Educational Outreach Program in Genetics and Biotechnology.
Recent advances in research and biotechnology are making genetics and genomics increasingly relevant to the lives and health of the general public. For the public to make informed healthcare and publi...
Industry progress report on neuro-oncology: a biotech update.
With steadily rising revenue and large numbers of clinical trials utilizing novel treatment strategies, the field of neuro-oncology is at the core of the growing cancer therapy industry. In June 2012,...
